- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
The Board of Dr. Lal PathLabs has approved a third interim dividend of ₹6 per equity share, amounting to a 60% payout on a ₹10 face value, with the record date set for February 5, 2025. This dividend is to be dispatched within 30 days following the declaration. Additionally, the Board acknowledged the voluntary liquidation of its wholly owned subsidiary, Suburban Diagnostics (India) Pvt. Ltd., aiming for an expedited consolidation of its operations back into the parent company, which may streamline their overall structure and reduce administrative costs.